![Omid Farokhzad](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 9 M $ al 31/08/2026
Fundador de 5 empresas diferentes, entre ellas Seer, Inc. (California), Selecta Biosciences, Inc. y DNIB Unwind, Inc. Omid C. Farokhzad es un empresario y es presidente y director ejecutivo de Seer, Inc. (California) (que fundó en 2017). También forma parte del consejo de Placon Therapeutics, Inc. En su carrera anterior fue presidente de Selecta Biosciences, Inc. (que fundó la empresa en 2007), profesor asociado de la Facultad de Medicina de Harvard, director de DNIB Unwind, Inc. y director de Tarveda Therapeutics, Inc. El Dr. Farokhzad se doctoró y se graduó en la Facultad de Medicina de la Universidad de Boston y obtuvo un MBA en el Instituto Tecnológico de Massachusetts.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
SEER, INC. CLASS A 7,95 % | 11/05/2026 | 4.403.724 ( 7,95 % ) | 9 M $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SEER, INC. | Director Ejecutivo | 01/03/2018 |
Placon Therapeutics, Inc.
 Placon Therapeutics, Inc. BiotechnologyHealth Technology Develops novel platinum therapies | Director/Miembro de la Junta | - |
Xlink Therapeutics, Inc. | Fundador | - |
PrognomIQ, Inc.
 PrognomIQ, Inc. Medical SpecialtiesHealth Technology Develops and commercializes multi-omics human tests for cancer and other diseases | Fundador | 01/01/2020 |
Xira Connect, Inc. | Director/Miembro de la Junta | 01/08/2019 |
| Empresas | Cargo | Fin |
|---|---|---|
Senti Biosciences, Inc.
 Senti Biosciences, Inc. BiotechnologyHealth Technology Develops a synthetic biology platform that enables to program next-generation cell and gene therapies | Director/Miembro de la Junta | 25/11/2024 |
| DYNC SPL | Presidente | 01/06/2022 |
| CARTESIAN THERAPEUTICS, INC. | Fundador | 19/11/2019 |
Tarveda Therapeutics, Inc.
 Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops cancer therapeutics and drugs | Fundador | 01/01/2019 |
| ░░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 15 |
|---|---|
DNIB Unwind, Inc.
 DNIB Unwind, Inc. BiotechnologyHealth Technology Develops biopharmaceutical preparations | Health Technology |
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Develops targeted immunotherapies and vaccines to treat and prevent diseases | Health Technology |
Semaphore, Inc.
 Semaphore, Inc. Packaged SoftwareTechnology Services Develops and distributes advanced financial and project management software | Technology Services |
The Brigham & Women's Hospital, Inc.
 The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tarveda Therapeutics, Inc.
Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops cancer therapeutics and drugs | Health Technology |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston University School of Medicine
 Boston University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Placon Therapeutics, Inc.
Placon Therapeutics, Inc. BiotechnologyHealth Technology Develops novel platinum therapies | Health Technology |
Seer, Inc. (California)
 Seer, Inc. (California) BiotechnologyHealth Technology Provides research and development services for biotechnology | Health Technology |
PrognomIQ, Inc.
PrognomIQ, Inc. Medical SpecialtiesHealth Technology Develops and commercializes multi-omics human tests for cancer and other diseases | Health Technology |
Dynamics Special Purpose Corp.
 Dynamics Special Purpose Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Xlink Therapeutics, Inc. | |
Xira Connect, Inc. | |
Senti Biosciences, Inc.
Senti Biosciences, Inc. BiotechnologyHealth Technology Develops a synthetic biology platform that enables to program next-generation cell and gene therapies | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
